Table 2.
Comorbidities in non-alcoholic steatohepatitis (NASH) and non-NASH patients
| Variable | NASH patients (n= 129) | Non-NASH patients (n= 775) | P-value |
|---|---|---|---|
| Hypertensiona, n (%) | 97 (75%) | 315 (41%) | <0.001 |
| Diabetesa, n (%) | 76 (59%) | 135 (17%) | <0.001 |
| Obesity (BMI >30 kg/m2), n (%) | 88 (68%) | 211 (28%) | <0.001 |
| Hypercholesterolaemiaa, n (%) | 29 (22%) | 98 (12%) | 0.003 |
| Chronic renal insufficiencyb, n (%) | 21 (16%) | 41 (5%) | <0.001 |
| Coronary artery diseaseb, n (%) | 8 (6%) | 21 (3%) | 0.04 |
| Cerebrovascular diseaseb, n (%) | 6 (5%) | 11 (1%) | 0.01 |
a
Patients were included only if they were using a hypertensive medication (excluding Nadolol) or a diabetes medication including insulin or an oral hypoglycaemic, or a cholesterol-lowering agent at the time of listing for liver transplant.
b
Patients were included based upon medical history at the time of listing for liver transplant. Patients with acute or diuretic-induced renal dysfunction were not included.
BMI, body mass index.